Inactivation of PBRM1 and additional members of the SWI/SNF complexes are associated with CIN [121,122], and a pre-clinical study showed that truncal PBRM1 alterations may be exploited through CIN-inducing therapies [123]. This evidence concerns the gene PBRM1 and cervical squamous intraepithelial neoplasia.